Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

72.09
-5.8100-7.46%
Post-market: 73.000.9100+1.26%19:55 EDT
Volume:4.36M
Turnover:317.52M
Market Cap:10.02B
PE:-10.04
High:74.42
Open:73.88
Low:71.66
Close:77.90
52wk High:88.31
52wk Low:35.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:3.44
T/O Rate:3.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-57.77
PE(LYR):-11.02

Loading ...

Cytokinetics, Incorporated : Leerink Partners Raises Target Price to $103 from $100

THOMSON REUTERS
·
Aug 10

Truist Adjusts Price Target on Cytokinetics to $112 From $106, Maintains Buy Rating

MT Newswires Live
·
Aug 10

Cytokinetics' Q2 Beat Highlights Myqorzo Launch Strength, RBC Says

MT Newswires Live
·
Aug 08

Cytokinetics price target raised to $85 from $83 at BofA

TIPRANKS
·
Aug 07

Cytokinetics Price Target Raised to $112.00/Share from $102.00 by Needham

Dow Jones
·
Aug 07

RBC Capital Adjusts PT on Cytokinetics to $112 From $117, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Cytokinetics price target raised to $110 from $105 at Citizens

TIPRANKS
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Cytokinetics (CYTK) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 07

Cytokinetics, Incorporated Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Cytokinetics Q2 FY26 Net Loss Widens to $198.76 Million; Revenue Drops to $28.62 Million

Reuters
·
Aug 07

Cytokinetics Q2 EPS $(1.50) Beats $(1.63) Estimate, Sales $28.624M Beat $17.382M Estimate

Benzinga Earnings
·
Aug 07

Cytokinetics Q2 Operating Expenses USD 207.796 Million

THOMSON REUTERS
·
Aug 07

Cytokinetics Q2 Basic EPS USD -1.5

THOMSON REUTERS
·
Aug 07

Cytokinetics Q2 R&D Revenue USD 25.334 Million

THOMSON REUTERS
·
Aug 07

Cytokinetics Inc Q2 Shr View $-1.64

THOMSON REUTERS
·
Aug 07

Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 07

Opus, Cytokinetics, Albertsons, Weatherford, Paysign Shock

TIPRANKS
·
Aug 01

Top Cytokinetics Executive Makes Eye-Catching Move With Insider Stock Sale

TIPRANKS
·
Jul 31

Earning Preview: Cytokinetics this quarter’s revenue is expected to increase by 629.37%, and institutional views are bullish

Earnings Agent
·
Jul 31

Cytokinetics EVP, Chief Commercial Officer Andrew Callos Sells 14,000 Common Shares for $1.12 Million

Reuters
·
Jul 31